Your browser doesn't support javascript.
loading
Development of a potent thrombin receptor ligand.
Feng, D M; Veber, D F; Connolly, T M; Condra, C; Tang, M J; Nutt, R F.
Afiliação
  • Feng DM; Department of Medicinal Chemistry, Merck Research Laboratories, West Point, Pennsylvania 19486, USA.
J Med Chem ; 38(20): 4125-30, 1995 Sep 29.
Article em En | MEDLINE | ID: mdl-7562949
ABSTRACT
The N-terminal thrombin receptor peptide H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe-OH (1) fully activates the thrombin receptor with an EC50 of 10 microM. Structural features in the tetradecapeptide which are responsible for receptor activation have been elucidated. Agonist potency has been enhanced 1000-fold with the design of the shortened peptide H-Ala-Phe(p-F)-Arg-Cha-HArg-Tyr-NH2 (56). This analog exhibits an EC50 of 0.01 microM and is the most potent agonist for receptor activation reported to date. The monoiodinated derivative H-Ala-Phe(p-F)-Arg-Cha-HArg-Tyr(3-I)-NH2 (59) exhibits an EC50 of 0.03 microM, a level sufficient for development of a radioligand.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Receptores de Trombina Limite: Humans Idioma: En Ano de publicação: 1995 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Receptores de Trombina Limite: Humans Idioma: En Ano de publicação: 1995 Tipo de documento: Article